HomeCBIO • NASDAQ
add
Crescent Biopharma Inc
Previous close
$12.55
Day range
$12.09 - $12.98
Year range
$10.83 - $63.00
Market cap
173.52M USD
Avg Volume
102.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.03M | — |
Net income | -21.79M | — |
Net profit margin | — | — |
Earnings per share | -3.72 | — |
EBITDA | -21.03M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.64M | — |
Total assets | 157.43M | — |
Total liabilities | 18.18M | — |
Total equity | 139.25M | — |
Shares outstanding | 19.55M | — |
Price to book | 1.76 | — |
Return on assets | -57.45% | — |
Return on capital | -69.08% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -21.79M | — |
Cash from operations | -16.40M | — |
Cash from investing | -140.00K | — |
Cash from financing | 146.86M | — |
Net change in cash | 130.32M | — |
Free cash flow | -7.53M | — |
About
Founded
2024
Headquarters
Website
Employees
33
